Live Markets
Tuesday, July 28, 2026·George Town, KY·29°·Partly Cloudy
Markets Open · NYSE·Newsletter·Masthead·
VOL. XII · NO. 117Established MMXIV · George Town, Grand CaymanAtlantic Edition · $4.50

The Cayman Journal

Finance · Business · Technology · Caribbean & Global Affairs
Markets · Healthcare

Penumbra, Inc. (PEN)

NYQ · Medical Devices

$319.99+0.50 (+0.16%)Quote refreshed

Sources: Yahoo Finance (quote, statistics) · SEC EDGAR (filings, insider trades, 13F holders) · company filings & press wires

Market Cap
$12.59B
P/E (TTM)
73.56
EPS
$4.35
Div Yield
52W Range
$221.26–$362.41
Beta
0.70

Company overview

Next earnings: 2026-07-28(0d)

Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. It offers computer-assisted vacuum thrombectomy; peripheral thrombectomy products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX. It also provides access products, including guide catheters and the Penumbra distal delivery catheters under the Neuron, Neuron MAX, BENCHMARK, BMX, DDC, Access25; MIDWAY, and PX SLIM brands; Penumbra System, an integrated mechanical thrombectomy system comprising reperfusion catheters and separators, the 3D Revascularization device, aspiration tubing, aspiration pump, and other components and accessories under the Penumbra RED, SENDit, JET, ACE, BMX, Max, 3D Revascularization Device, and Penumbra ENGINE brands; and neuro embolization coiling systems that include the Penumbra Coil 400, for the treatment of aneurysms and other complex lesions, detachable coils of neurovascular lesions under the Penumbra SMART COIL, SwiftSET, and Penumbra SwiftPAC Coil brands; and POD400 and PAC400 brands. In addition, it provides peripheral embolization products, such as Ruby Embolization Platform, which consists of detachable coils for peripheral applications; Ruby LP and XL Embolization Platform; Penumbra LANTERN Delivery Microcatheter, a low-profile microcatheter with a high-flow lumen; POD (Penumbra Occlusion Device) System, a single device solution; Packing Coil LP; and Packing Coil, a complementary device for use in other peripheral embolization products. Further, it offers neurosurgical tools comprising the Artemis Neuro Evacuation Device for surgical removal of fluid and tissue from the ventricles and cerebrum. It sells its products through direct sales organizations and distributors. The company was incorporated in 2004 and is based in Alameda, California.

Peers in Medical Devices

All in industry →

Recent press releases

April 2026

3 months ago425Healthcare

Penumbra Inc — 425 Filing

PENPenumbra Inc

# 📄 What This Document Is This is a **Form 425 filing** with the SEC. Think of it as a public disclosure of communication related to a major business deal. In this case, Penumbra is letting the world know it's sending final voting reminders to its shareholders about the planned merger with Boston S

Read summaryView on SEC EDGAR
3 months ago425Healthcare

PEN Shareholders Vote May 6 on Boston Scientific Acquisition

PENPenumbra Inc

# 🧾 What This Document Is This is a transcript from **Boston Scientific's Q1 2026 earnings call**, filed with the SEC as a Form 425. This filing type is used when companies want to share information about "business combinations"—in this case, their planned **acquisition of Penumbra, Inc.** Think of

Read summaryView on SEC EDGAR

SEC filings

All filings →
2 recent filings shown in the timeline above. View all SEC filings →

Penumbra, Inc. has no reported insider trades in the last 90 days.

Institutional holders

All holders →
As of 2025-12-31 · prior 2025-09-30
4,141,230 sh-0.7%
3,770,569 sh-1.7%
767,832 sh+163.1%
594,112 sh+165.8%
FMR LLC$1.60B
5,131,942 sh-12.9%
471,348 sh+51.9%
212,956 sh● NEW

People at Penumbra, Inc.

All people →

Quarterly financials

Full financials →
Revenue trend
03/25
$324.1M
NI $39.2M
06/25
$339.5M
NI $45.3M
09/25
$354.7M
NI $45.9M
RevenueNI = Net Income
EPS trend (diluted)
Latest: $1.17
Prior: $1.15
Revenue sparkline